Market Overview

Benzinga's Top Upgrades, Downgrades For November 3, 2020

Share:

Upgrades

  • For Matson Inc (NYSE: MATX), Stephens & Co. upgraded the previous rating of Equal-Weight to the current rating Overweight. In the third quarter, Matson showed an EPS of $1.63, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of 53.71 and a 52-week-low of 23.75. At the end of the last trading period, Matson closed at $52.22.
  • For Inspire Medical Systems Inc (NYSE: INSP), Oppenheimer upgraded the previous rating of Underperform to the current rating Perform. In the third quarter, Inspire Medical Systems showed an EPS of $0.39, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of 135.2 and a 52-week-low of 40.53. At the end of the last trading period, Inspire Medical Systems closed at $121.49.
  • For IPG Photonics Corp (NASDAQ: IPGP), Northcoast Research upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, IPG Photonics showed an EPS of $1.29, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of 202.58 and a 52-week-low of 98.04. IPG Photonics closed at $190.65 at the end of the last trading period.
  • According to B of A Securities, the prior rating for CNA Financial Corp (NYSE: CNA) was changed from Underperform to Neutral. CNA Financial earned $0.71 in the third quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of 51.3 and a 52-week-low of 25.18. At the end of the last trading period, CNA Financial closed at $31.61.
  • For Arista Networks Inc (NYSE: ANET), B of A Securities upgraded the previous rating of Neutral to the current rating Buy. Arista Networks earned $2.42 in the third quarter, compared to $2.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of 267.3 and a 52-week-low of 156.63. Arista Networks closed at $216.13 at the end of the last trading period.
  • According to Goldman Sachs, the prior rating for Pinduoduo Inc (NASDAQ: PDD) was changed from Neutral to Buy. In the second quarter, Pinduoduo showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. At the moment, the stock has a 52-week-high of 98.96 and a 52-week-low of 30.2. Pinduoduo closed at $91.62 at the end of the last trading period.
  • According to Morgan Stanley, the prior rating for Constellation Brands Inc (NYSE: STZ) was changed from Equal-Weight to Overweight. Constellation Brands earned $2.76 in the second quarter, compared to $2.72 in the year-ago quarter. The current stock performance of Constellation Brands shows a 52-week-high of 208.55 and a 52-week-low of 104.28. Moreover, at the end of the last trading period, the closing price was at $176.36.
  • Morgan Stanley upgraded the previous rating for Monster Beverage Corp (NASDAQ: MNST) from Equal-Weight to Overweight. In the second quarter, Monster Beverage showed an EPS of $0.59, compared to $0.53 from the year-ago quarter. At the moment, the stock has a 52-week-high of 87.05 and a 52-week-low of 50.06. Monster Beverage closed at $77.92 at the end of the last trading period.
  • JP Morgan upgraded the previous rating for Paycom Software Inc (NYSE: PAYC) from Underweight to Neutral. For the second quarter, Paycom Software had an EPS of $0.62, compared to year-ago quarter EPS of $0.75. The current stock performance of Paycom Software shows a 52-week-high of 397.51 and a 52-week-low of 163.42. Moreover, at the end of the last trading period, the closing price was at $360.91.
  • For BP PLC (NYSE: BP), Morgan Stanley upgraded the previous rating of Underweight to the current rating Equal-Weight. In the third quarter, BP showed an EPS of $0.03, compared to $0.66 from the year-ago quarter. The current stock performance of BP shows a 52-week-high of 40.08 and a 52-week-low of 14.74. Moreover, at the end of the last trading period, the closing price was at $16.10.

 

Downgrades

  • According to Oppenheimer, the prior rating for SolarEdge Technologies Inc (NASDAQ: SEDG) was changed from Outperform to Perform. In the third quarter, SolarEdge Technologies showed an EPS of $1.21, compared to $1.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of 317.88 and a 52-week-low of 67.02. SolarEdge Technologies closed at $267.72 at the end of the last trading period.
  • Susquehanna downgraded the previous rating for Skechers USA Inc (NYSE: SKX) from Positive to Neutral. For the third quarter, Skechers USA had an EPS of $0.53, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of 44.5 and a 52-week-low of 17.06. Skechers USA closed at $30.50 at the end of the last trading period.
  • For The Mosaic Co (NYSE: MOS), ScotiaBank downgraded the previous rating of Sector Outperform to the current rating Sector Perform. For the third quarter, Mosaic had an EPS of $0.23, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of 22.5 and a 52-week-low of 6.5. Mosaic closed at $19.56 at the end of the last trading period.
  • For Endurance International Group Holdings Inc (NASDAQ: EIGI), Credit Suisse downgraded the previous rating of Outperform to the current rating Neutral. For the third quarter, Endurance Intl Gr Hldgs had an EPS of $0.05, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of 9.48 and a 52-week-low of 1.31. Endurance Intl Gr Hldgs closed at $9.41 at the end of the last trading period.
  • According to Raymond James, the prior rating for IPG Photonics Corp (NASDAQ: IPGP) was changed from Outperform to Market Perform. IPG Photonics earned $1.29 in the third quarter, compared to $1.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of 202.58 and a 52-week-low of 98.04. IPG Photonics closed at $190.65 at the end of the last trading period.
  • Piper Sandler downgraded the previous rating for Pacific Biosciences of California Inc (NASDAQ: PACB) from Overweight to Neutral. In the third quarter, Pacific Biosciences showed an EPS of $0.14, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of 15.12 and a 52-week-low of 2.2. At the end of the last trading period, Pacific Biosciences closed at $13.25.
  • According to Keefe, Bruyette & Woods, the prior rating for Greenhill & Co Inc (NYSE: GHL) was changed from Market Perform to Underperform. In the third quarter, Greenhill & Co showed an EPS of $0.49, compared to $0.63 from the year-ago quarter. At the moment, the stock has a 52-week-high of 23.08 and a 52-week-low of 7.28. Greenhill & Co closed at $13.05 at the end of the last trading period.
  • Raymond James downgraded the previous rating for Jounce Therapeutics Inc (NASDAQ: JNCE) from Strong Buy to Market Perform. For the second quarter, Jounce Therapeutics had an EPS of $0.82, compared to year-ago quarter EPS of $0.21. At the moment, the stock has a 52-week-high of 11.7201 and a 52-week-low of 2.85. Jounce Therapeutics closed at $6.82 at the end of the last trading period.

 

Initiations

  • With a current rating of Outperform, RBC Capital initiated coverage on Spruce Biosciences Inc (NASDAQ: SPRB). The price target seems to have been set at $28.00 for Spruce Biosciences. The current stock performance of Spruce Biosciences shows a 52-week-high of 22.515 and a 52-week-low of 15.38. Moreover, at the end of the last trading period, the closing price was at $20.30.
  • With a current rating of Buy, Citigroup initiated coverage on Shattuck Labs Inc (NASDAQ: STTK). The price target seems to have been set at $36.00 for Shattuck Labs. The current stock performance of Shattuck Labs shows a 52-week-high of 27.245 and a 52-week-low of 19.5001. Moreover, at the end of the last trading period, the closing price was at $26.87.
  • B of A Securities initiated coverage on NICE Ltd (NASDAQ: NICE) with a Buy rating. The price target for NICE is set to $280.00. In the second quarter, NICE showed an EPS of $1.37, compared to $1.25 from the year-ago quarter. The stock has a 52-week-high of 240.58 and a 52-week-low of 110.59. At the end of the last trading period, NICE closed at $229.60.
  • For Kronos Bio Inc (NASDAQ: KRON), Cowen & Co. initiated coverage, by setting the current rating at Outperform. The current stock performance of Kronos Bio shows a 52-week-high of 33.65 and a 52-week-low of 25.57. Moreover, at the end of the last trading period, the closing price was at $26.93.
  • With a current rating of Buy, Truist Securities initiated coverage on HOOKIPA Pharma Inc (NASDAQ: HOOK). The price target seems to have been set at $21.00 for HOOKIPA Pharma. HOOKIPA Pharma earned $0.28 in the second quarter, compared to $0.63 in the year-ago quarter. The current stock performance of HOOKIPA Pharma shows a 52-week-high of 14.3662 and a 52-week-low of 5.8. Moreover, at the end of the last trading period, the closing price was at $9.82.
  • With a current rating of Underperform, Baird initiated coverage on Editas Medicine Inc (NASDAQ: EDIT). The price target seems to have been set at $14.00 for Editas Medicine. For the second quarter, Editas Medicine had an EPS of $0.43, compared to year-ago quarter EPS of $0.69. The stock has a 52-week-high of 39.96 and a 52-week-low of 14.01. At the end of the last trading period, Editas Medicine closed at $31.30.
  • SVB Leerink initiated coverage on Spruce Biosciences Inc (NASDAQ: SPRB) with an Outperform rating. The price target for Spruce Biosciences is set to $35.00. The current stock performance of Spruce Biosciences shows a 52-week-high of 22.515 and a 52-week-low of 15.38. Moreover, at the end of the last trading period, the closing price was at $20.30.
  • With a current rating of Buy, Fearnleys initiated coverage on Cheniere Energy Inc (AMEX: LNG). The price target seems to have been set at $61.00 for Cheniere Energy. For the second quarter, Cheniere Energy had an EPS of $0.78, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of 67.11 and a 52-week-low of 27.06. At the end of the last trading period, Cheniere Energy closed at $47.06.
  • Goldman Sachs initiated coverage on Kronos Bio Inc (NASDAQ: KRON) with a Buy rating. The price target for Kronos Bio is set to $45.00. The stock has a 52-week-high of 33.65 and a 52-week-low of 25.57. At the end of the last trading period, Kronos Bio closed at $26.93.
  • With a current rating of Buy, Goldman Sachs initiated coverage on Chindata Group Holdings Ltd (NASDAQ: CD). The price target seems to have been set at $17.60 for Chindata Group Holdings. The stock has a 52-week-high of 16.76 and a 52-week-low of 13.12. At the end of the last trading period, Chindata Group Holdings closed at $13.84.
  • With a current rating of Overweight, Piper Sandler initiated coverage on Kronos Bio Inc (NASDAQ: KRON). The price target seems to have been set at $50.00 for Kronos Bio. The current stock performance of Kronos Bio shows a 52-week-high of 33.65 and a 52-week-low of 25.57. Moreover, at the end of the last trading period, the closing price was at $26.93.
  • With a current rating of Outperform, Credit Suisse initiated coverage on Spruce Biosciences Inc (NASDAQ: SPRB). The price target seems to have been set at $28.00 for Spruce Biosciences. At the moment, the stock has a 52-week-high of 22.515 and a 52-week-low of 15.38. Spruce Biosciences closed at $20.30 at the end of the last trading period.
 

Related Articles (BP + ANET)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
MRTXHC Wainwright & Co.Maintains257.0
NVDATruist SecuritiesMaintains672.0
NVDASusquehannaMaintains625.0
BLKBMO CapitalMaintains715.0
BLKDeutsche BankMaintains838.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com